Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in Elective Abdominal Hysterectomy
NCT03302208Phase 3Completed
- Start
- Jun 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial comparing Pregabalin Group with Placebo Group (2 arms). Primary endpoint: Inhalational anaesthetic drug requirements at 3 hours. Started Jun 2017; status: completed.
02
Drugs
pregabalin
Beyond the preview
Go deeper on NCT03302208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302208.